BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 30928109)

  • 21. Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report.
    Oh C; Youn JK; Han JW; Kim GB; Kim HY; Jung SE
    Medicine (Baltimore); 2016 Oct; 95(41):e4823. PubMed ID: 27741102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot.
    Yamamura K; Sakamoto I; Morihana E; Hirata Y; Nagata H; Yamasaki Y; Okumura Y; Kohashi K; Koto K; Tsutsui H; Ohga S
    Int J Cardiol; 2019 Jul; 287():121-126. PubMed ID: 31006598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.
    Ghaferi AA; Hutchins GM
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1348-52. PubMed ID: 15942576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fontan-associated liver disease: pathophysiology, investigations, predictors of severity and management.
    Keung CY; Zentner D; Gibson RN; Phan DH; Grigg LE; Sood S; Nicoll AJ
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):907-915. PubMed ID: 31851099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.
    Wu FM; Jonas MM; Opotowsky AR; Harmon A; Raza R; Ukomadu C; Landzberg MJ; Singh MN; Valente AM; Egidy Assenza G; Perez-Atayde AR
    J Heart Lung Transplant; 2015 Jul; 34(7):883-91. PubMed ID: 25863891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of a primary liver cancer with an unusual histologic appearance as a late Fontan complication.
    Matsuyama TA; Ohuchi H; Saito K; Kondo F; Fukusato T; Ishibashi-Ueda H
    Pathol Res Pract; 2019 Jun; 215(6):152366. PubMed ID: 30857653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation.
    Surrey LF; Russo P; Rychik J; Goldberg DJ; Dodds K; O'Byrne ML; Glatz AC; Rand EB; Lin HC
    Hum Pathol; 2016 Nov; 57():106-115. PubMed ID: 27476041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Fontan operation on liver stiffness in children with single ventricle physiology.
    DiPaola FW; Schumacher KR; Goldberg CS; Friedland-Little J; Parameswaran A; Dillman JR
    Eur Radiol; 2017 Jun; 27(6):2434-2442. PubMed ID: 27752831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fontan-associated liver disease: Diagnosis, surveillance, and management.
    de Lange C; Möller T; Hebelka H
    Front Pediatr; 2023; 11():1100514. PubMed ID: 36937979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acoustic radiation force impulse of the liver after Fontan operation: Correlation with cardiopulmonary exercise test.
    Di Maria MV; Silverman L; Younoszai AK; Meyers ML; Capocelli KE; Narkewicz MR
    Congenit Heart Dis; 2018 May; 13(3):444-449. PubMed ID: 29473337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of the liver in the survivors of adult heart transplant for a failing Fontan circulation.
    Broda CR; Alonso-Gonzalez R; Ghanekar A; Gulamhusein A; McDonald M; Luk A; Kobulnik J; Billia F; Heggie J; Jariani M; Honjo O; Barron D; Hickey E; Roche SL
    J Heart Lung Transplant; 2022 Mar; 41(3):283-286. PubMed ID: 34953719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FibroSURE and elastography poorly predict the severity of liver fibrosis in Fontan-associated liver disease.
    Schachter JL; Patel M; Horton SR; Mike Devane A; Ewing A; Abrams GA
    Congenit Heart Dis; 2018 Sep; 13(5):764-770. PubMed ID: 30101472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
    Suzuki H; Niizeki T; Shirono T; Koteda Y; Kinjyo Y; Mizukami N; Koda M; Ota S; Nakano M; Okamura S; Iwamoto H; Shimose S; Noda Y; Kamachi N; Kajiwara A; Suda K; Akiba J; Yano H; Kuromatsu R; Koga H; Torimura T
    Intern Med; 2022 Apr; 61(8):1145-1150. PubMed ID: 34565776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
    Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE.
    Suna N; Özer Etik D; Öcal S; Hilmioğlu F
    Gastroenterol Nurs; 2018; 41(1):68-71. PubMed ID: 29373356
    [No Abstract]   [Full Text] [Related]  

  • 38. Fontan-Associated Liver Disease: A Review.
    Heering G; Lebovics N; Agarwal R; Frishman WH; Lebovics E
    Cardiol Rev; 2024 Mar; ():. PubMed ID: 38477576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
    Emamaullee J; Martin S; Goldbeck C; Rocque B; Barbetta A; Kohli R; Starnes V
    Ann Surg; 2022 Sep; 276(3):482-490. PubMed ID: 35766375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.